Regional West Health Services says a Scottsbluff psychiatry clinic has introduced Spravato, a monitored nasal-spray option for some adults in western Nebraska.
Spravato introduced in Scottsbluff
Regional West Health Services reports that a psychiatry clinic in Scottsbluff has introduced Spravato as a new treatment option. The source describes the addition as an expansion of available depression-treatment options in western Nebraska.
According to Regional West Health Services, Spravato is an FDA-approved nasal spray. The source says it is intended for adults who have tried two or more antidepressants without getting the desired results.
Who the option is described for
Regional West Health Services identifies adults who have tried at least two antidepressants without desired results as the group for whom the newly introduced option is described. The source frames Spravato as an option for treatment-resistant depression.
The source does not describe Spravato as a replacement for other depression treatments. Instead, Regional West Health Services presents it as an additional option introduced by the Scottsbluff psychiatry clinic.
Monitored sessions over eight weeks
Regional West Health Services says Spravato is given during monitored sessions lasting two hours. The source states that these sessions take place over an eight-week period.
The monitoring and session schedule are part of the treatment arrangement described by Regional West Health Services. The source specifically characterizes the medication as a nasal spray and says the sessions are monitored.
What this means for Nebraska patients
Regional West Health Services’ announcement signals another treatment option in western Nebraska for adults described by the source as having tried two or more antidepressants without desired results. People looking for treatment locally can use the directory, which lists 11 published clinics in Nebraska, to identify available options near them.
This is general information, not medical advice.
More Nebraska reporting on treatment updates.
This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.